Integrated Single-Cell and Bulk Transcriptome Analysis Reveals the Prognostic Significance and Immune Regulatory Mechanisms of Sialylation in Hepatocellular Carcinoma.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
quality control, clustering, annotation, and risk-cell subpopulation identification using Seurat/Harmony/SCISSOR
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Drug sensitivity analysis revealed higher sensitivity to chemotherapeutic agents in high-risk patients. Integrated transcriptomics establishes aberrant sialylation as a key LIHC prognostic biomarker and therapeutic target by stratifying risk subgroups and revealing immunosuppressive microenvironment alterations.
Liver Hepatocellular Carcinoma (LIHC) is a high-mortality primary liver cancer.
APA
Yao Y, Song D, et al. (2026). Integrated Single-Cell and Bulk Transcriptome Analysis Reveals the Prognostic Significance and Immune Regulatory Mechanisms of Sialylation in Hepatocellular Carcinoma.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 40(4), e71562. https://doi.org/10.1096/fj.202503688R
MLA
Yao Y, et al.. "Integrated Single-Cell and Bulk Transcriptome Analysis Reveals the Prognostic Significance and Immune Regulatory Mechanisms of Sialylation in Hepatocellular Carcinoma.." FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol. 40, no. 4, 2026, pp. e71562.
PMID
41661103 ↗
Abstract 한글 요약
Liver Hepatocellular Carcinoma (LIHC) is a high-mortality primary liver cancer. Its treatment and prognosis are highly dependent on disease stage and liver function reserve, necessitating novel biomarkers and optimized therapeutic strategies. Sialylation frequently exhibits abnormal elevation (hypersialylation) in cancers and is recognized as both an important malignant marker and a potential therapeutic target. Transcriptomic, mutational, and clinical LIHC data were procured from TCGA/GEO, extracting sialylation-related genes. Single-cell data underwent quality control, clustering, annotation, and risk-cell subpopulation identification using Seurat/Harmony/SCISSOR. AUCell quantified SRGs activity to identify key differentially expressed SRGs. 10 machine learning algorithms (e.g., SVM, Enet, CoxBoost) were integrated; the optimal StepCox + Enet model was selected via cross-validation, stratifying patients by risk score. The model's clinical utility was validated through GSEA, PPI networks, immune infiltration (CIBERSORT/ssGSEA), and drug sensitivity profiling. This integrated study combined single-cell and bulk transcriptomic data to develop an 11-gene sialylation-related prognostic model for LIHC, demonstrating robust predictive accuracy (AUC > 0.74 across cohorts). High-risk patients exhibited myeloid-driven biology, including enhanced SPP1-mediated cell-cell signaling, TP53 mutations, metabolic dysregulation, and an immunosuppressive microenvironment with elevated TIDE scores. In contrast, the low-risk group displayed active anti-tumor immunity and metabolic homeostasis. Drug sensitivity analysis revealed higher sensitivity to chemotherapeutic agents in high-risk patients. Integrated transcriptomics establishes aberrant sialylation as a key LIHC prognostic biomarker and therapeutic target by stratifying risk subgroups and revealing immunosuppressive microenvironment alterations.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Ionizable mesoporous silica nanoparticle-mediated siAURKB delivery for colorectal cancer therapy.
- The comparative diagnostic and therapeutic application value of FAPI PET/CT and F-FDG PET/CT in oncology.
- Microbiota in cancer: current understandings and future perspectives.
- Parthenolide and Its Derivatives in the Treatment of Respiratory Tract Diseases: Therapeutic Effects and Molecular Mechanisms.
- Re: Fecal Microbiota Transplantation plus Pembrolizumab and Axitinib in Metastatic Renal Cell Carcinoma: The Randomized Phase 2 TACITO Trial.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.